Cancer patients who received specialized mental health support as part of their treatment plan were more likely to see improvements in their quality of life and reductions in pain, depression and fatigue, according to a study ...
Mar 12, 2024
0
61
Women with a type of ovarian cancer known as germ cell tumors have a worse prognosis than men with similar tumors (i.e., testicular cancer). After five years with the disease, 98% of men were alive while the survival rate ...
Mar 12, 2024
0
0
Mayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a significant departure from traditional AI models which learn solely from data.
Mar 12, 2024
0
27
University of Queensland research has led to the development of a practical framework to help medical professionals around the world diagnose and manage early menopause.
Mar 8, 2024
0
0
A high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has—for the first time—enabled researchers to see how individual living cancer ...
Mar 6, 2024
0
19
A new study that provides the U.K.'s first comprehensive assessment of cancer during pregnancy can lead to improved treatment, outcomes and experiences of patients and their families, say experts.
Mar 5, 2024
0
0
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing ...
Mar 4, 2024
0
0
There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times ...
Mar 4, 2024
0
0
Experts at University of Michigan Health Rogel Cancer Center have conducted the first study evaluating the effectiveness of a targeted drug for patients with salivary gland cancers (SGC).
Mar 1, 2024
0
0
The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.
Mar 1, 2024
0
92
